Clinical trial
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With…
NCT00329160 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00329160 |
|---|---|
| Title | Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease |
| Official title | A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular Ultrasonography |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Shionogi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesteremia |
| Intervention type | Drug |
| Interventions | Rosuvastatin, HMG CoA inhibitor |
| Enrollment | 214 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | May 24, 2006 |
| Last update posted | Aug 31, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: